<img src="https://trc.taboola.com/1321591/log/3/unip?en=page_view" width="0" height="0" style="display:none">
Fact Check Library

Fact Check with Logically.

Download the Free App Today




COVID-19 human antibody that may limit the spread of the virus has been identified.

The researchers have spotted a cross-reactive human antibody that might limit the spread of COVID-19 infection.

On August 25, 2020, a study by the researchers at MassBiologics of the University of Massachusetts Medical School published in Nature Communications stated that the COVID specific IgA monoclonal antibodies may provide effective immunity in the respiratory system against the COVID-19 infection a potentially critical feature of an effective vaccine. It is claimed that the human monoclonal antibody (MAB) to SARS-CoV-2 spike proteins, blocks ACE2 receptor binding the mucosal tissue of the respiratory tract which potentially prevents or limits SARS-CoV-2 causing COVID-19 disease.

The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.

Have a question or correction on one of our fact-checks?

If you think a claim has been misjudged or requires correction, please send us evidence to support your error claim. We will revisit our evidence and verdict and conduct additional research to verify new information.

Fact Check of the Day


The BBC censored the crowd booing Boris Johnson at the Queen’s Platinum Jubilee celebrations.